Mammalian Genome

, Volume 18, Issue 12, pp 817–831

Mammary cancer susceptibility: human genes and rodent models



Breast cancer is a complex disease, showing a strong genetic component. Several human susceptibility genes have been identified, especially in the last few months. Most of these genes are low-penetrance genes and it is clear that numerous other susceptibility genes remain to be identified. The function of several susceptibility genes indicates that one critical biological pathway is the DNA damage response. However, other pathways certainly play a significant role in breast cancer susceptibility. Rodent models of breast cancer are useful models in two respects. They can help identify new mammary susceptibility genes by taking advantage of the very divergent susceptibilities exhibited by different mouse or rat strains and carrying out relevant genetic analyses. They also provide investigators with experimental systems that can help decipher the mechanism(s) of resistance to mammary cancer. Recent genetic and biological results obtained with mouse and especially with rat strains indicate that (1) numerous quantitative trait loci control mammary cancer susceptibility or resistance, with distinct loci acting in different strains, and (2) distinct resistance mechanisms operate in different rat resistant strains, precocious mammary differentiation being one of these mechanisms.


  1. Ahmed M, Rahman N (2006) ATM and breast cancer susceptibility. Oncogene 25:5906–5911PubMedCrossRefGoogle Scholar
  2. Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25:5898–5905PubMedCrossRefGoogle Scholar
  3. Arif JM, Smith WA, Gupta RC (1999) DNA adduct formation and persistence in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene. Carcinogenesis 20:1147–1150PubMedCrossRefGoogle Scholar
  4. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ (2007) Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67:4687–4694PubMedCrossRefGoogle Scholar
  5. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33 Suppl:238–244PubMedCrossRefGoogle Scholar
  6. Bau DT, Mau YC, Ding SL, Wu PE, Shen CY (2007) DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 28:1726–1730PubMedCrossRefGoogle Scholar
  7. Baynes C, Healey CS, Pooley KA, Scollen S, Luben RN, et al. (2007) Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Res 9:R27PubMedCrossRefGoogle Scholar
  8. Benton ME, Chen KS, Haag JD, Sattler CA, Gould MN (1999) Precocious differentiation of the virgin Wistar-Kyoto rat mammary gland. Endocrinology 140:2659–2671PubMedCrossRefGoogle Scholar
  9. Bhoumik A, Takahashi S, Breitweiser W, Shiloh Y, Jones N, et al. (2005) ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol Cell 18:577–587PubMedCrossRefGoogle Scholar
  10. Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, et al. (2007) Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol 170:2030–2041PubMedCrossRefGoogle Scholar
  11. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, et al. (2006) Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66:6421–6431PubMedCrossRefGoogle Scholar
  12. Bradbury AR, Olopade OI (2007) Genetic susceptibility to breast cancer. Rev Endocr Metab Disord 8:255-267PubMedCrossRefGoogle Scholar
  13. Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, et al. (2007) Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer 109:2627–2634PubMedCrossRefGoogle Scholar
  14. Callahan R, Smith GH (2000) MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 19:992–1001PubMedCrossRefGoogle Scholar
  15. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, et al. (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRefGoogle Scholar
  16. Catteau A, Harris WH, Xu CF, Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18:1957–1965PubMedCrossRefGoogle Scholar
  17. Chan KY, Ozcelik H, Cheung AN, Ngan HY, Khoo US (2002) Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 62:4151–4156PubMedGoogle Scholar
  18. Chang MY, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, et al. (2007) Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res 67:100–107PubMedCrossRefGoogle Scholar
  19. Coffey RJ Jr, Meise KS, Matsui Y, Hogan BL, Dempsey PJ, et al. (1994) Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res 54:1678–1683PubMedGoogle Scholar
  20. Cohen PR, Kohn SR, Kurzrock R (1991) Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 90:606–613PubMedGoogle Scholar
  21. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358:1389–1399CrossRefGoogle Scholar
  22. Cotroneo MS, Merry GM, Haag JD, Lan H, Shepel LA, et al. (2006) The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance. Oncogene 25:5011–5017PubMedCrossRefGoogle Scholar
  23. Cotroneo MS, Haag JD, Zan Y, Lopez CC, Thuwajit P, et al. (2007) Characterizing a rat Brca2 knockout model. Oncogene 26:1626–1635PubMedCrossRefGoogle Scholar
  24. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, et al. (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352–358PubMedCrossRefGoogle Scholar
  25. Cozma D, Lukes L, Rouse J, Qiu TH, Liu ET, et al. (2002) A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Genome Res 12:969–975PubMedCrossRefGoogle Scholar
  26. Crawford NP, Hunter KW (2006) New perspectives on hereditary influences in metastatic progression. Trends Genet 22:555–561PubMedCrossRefGoogle Scholar
  27. Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, et al. (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A 100:6682–6687PubMedCrossRefGoogle Scholar
  28. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, et al. (2002) Parameters for reliable results in genetic association studies in common disease. Nat Genet 30:149–150PubMedCrossRefGoogle Scholar
  29. Dankort DL, Muller WJ (2000) Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 19:1038–1044PubMedCrossRefGoogle Scholar
  30. Dao TL (1964) Carcinogenesis of mammary gland in rat. Prog Exp Tumor Res 14:157–216PubMedGoogle Scholar
  31. Demant P (2003) Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev Genet 4:721–734PubMedCrossRefGoogle Scholar
  32. Dickson C, Creer A, Fantl V (2000) Mammary gland oncogenes as indicators of pathways important in mammary gland development. Oncogene 19:1097–1101PubMedCrossRefGoogle Scholar
  33. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Ann Rev Immunol 22:329–360CrossRefGoogle Scholar
  34. Dunning WF, Curtis MR, Segaloff A (1953) Strain differences in response to estrone and the induction of mammary gland, adrenal, and bladder cancer in rats. Cancer Res 13:147–152PubMedGoogle Scholar
  35. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093PubMedCrossRefGoogle Scholar
  36. Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, et al. (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316–319PubMedCrossRefGoogle Scholar
  37. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122PubMedCrossRefGoogle Scholar
  38. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, et al. (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121:483–490PubMedCrossRefGoogle Scholar
  39. Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, et al. (2004) Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics 168:2113–2125PubMedCrossRefGoogle Scholar
  40. Gould MN (1986) Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. Cancer Res 46:1199–1202PubMedGoogle Scholar
  41. Gould M (1989) Modulation of mammary carcinogenesisby enhancer and suppressor genes. In: Genes and Signal Transduction in Multistage Carcinogenesis, Colburn NH (ed.) (New York: Dekker), pp 19–38Google Scholar
  42. Gould MN (1995) Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin Cancer Biol 6:147–152PubMedCrossRefGoogle Scholar
  43. Griffiths MM, Encinas JA, Remmers EF, Kuchroo VK, Wilder RL (1999) Mapping autoimmunity genes. Curr Opin Immunol 11:689–700PubMedCrossRefGoogle Scholar
  44. Gudmundsdottir K, Ashworth A (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25:5864–5874PubMedCrossRefGoogle Scholar
  45. Gullino PM, Pettigrew HM, Grantham FH (1975) N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54:401–414PubMedGoogle Scholar
  46. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12:954–961PubMedGoogle Scholar
  47. Haag JD, Newton MA, Gould MN (1992) Mammary carcinoma suppressor and susceptibility genes in the Wistar-Kyoto rat. Carcinogenesis 13:1933–1935PubMedCrossRefGoogle Scholar
  48. Haag JD, Shepel LA, Kolman BD, Monson DM, Benton ME, et al. (2003) Congenic rats reveal three independent Copenhagen alleles within the Mcs1 quantitative trait locus that confer resistance to mammary cancer. Cancer Res 63:5808–5812PubMedGoogle Scholar
  49. Hakem R, de la Pompa JL, Mak TW (1998) Developmental studies of Brca1 and Brca2 knock-out mice. J Mammary Gland Biol Neoplasia 3:431–445PubMedCrossRefGoogle Scholar
  50. Harris SR, Mehta RS, Hartle DK, Broderson JR, Bunce OR (1994) Failure of high fat diets to promote mammary cancers in spontaneously hypertensive rats. Cancer Lett 87:9–15PubMedCrossRefGoogle Scholar
  51. Hedrich H (1990) Genetic Monitoring of Inbred Strains of Rats (Stuttgart, New York: Gustav Fischer Verlag)Google Scholar
  52. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, et al. (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27:1593–1599PubMedCrossRefGoogle Scholar
  53. Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, et al. (2006) Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A 103:7753–7758PubMedCrossRefGoogle Scholar
  54. Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, et al. (2002) Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 94:1396–1406PubMedGoogle Scholar
  55. Hopper JL (2001) Genetic epidemiology of female breast cancer. Semin Cancer Biol 11:367–374PubMedCrossRefGoogle Scholar
  56. Hsu LC, Kennan WS, Shepel LA, Jacob HJ, Szpirer C, et al. (1994) Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res 54:2765–2770PubMedGoogle Scholar
  57. Humphreys RC, Hennighausen L (2000) Transforming growth factor alpha and mouse models of human breast cancer. Oncogene 19:1085–1091PubMedCrossRefGoogle Scholar
  58. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870–874PubMedCrossRefGoogle Scholar
  59. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, et al. (2001) Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 61:8866–8872PubMedGoogle Scholar
  60. Isaacs JT (1986) Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46:3958–3963PubMedGoogle Scholar
  61. Isaacs JT (1988) Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis. Cancer Res 48:2204–2213PubMedGoogle Scholar
  62. Isaacs JT (1991) A mammary cancer suppressor gene and its site of action in the rat. Cancer Res 51:1591–1595PubMedGoogle Scholar
  63. Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, et al. (2000) A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 19:1052–1058PubMedCrossRefGoogle Scholar
  64. Ke Y, Wu D, Princen F, Nguyen T, Pang Y, et al. (2007) Role of Gab2 in mammary tumorigenesis and metastasis. Oncogene 26:4951–4960PubMedCrossRefGoogle Scholar
  65. Kim U, Clifton KH, Furth J (1960) A highly inbred line of Wistar rats yielding spontaneous mammo-somatotropic pituitary and other tumors. J Natl Cancer Inst 24:1031–1055PubMedGoogle Scholar
  66. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646PubMedCrossRefGoogle Scholar
  67. Koch JG, Gu X, Han Y, El-Naggar AK, Olson MV, et al. (2007) Mammary tumor modifiers in BALB/cJ mice heterozygous for p53. Mamm Genome 18:300-309PubMedCrossRefGoogle Scholar
  68. Korkola JE, Archer MC (1999) Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions. Carcinogenesis 20:221–227PubMedCrossRefGoogle Scholar
  69. Korkola JE, Wood GA, Archer MC (1997) Resistance to chemically-induced mammary tumors in Copenhagen X nude-derived F2 athymic rats: evidence that T-cell immunity is not involved in Copenhagen resistance. Carcinogenesis 18:53–57PubMedCrossRefGoogle Scholar
  70. Kozak C, Peters G, Pauley R, Morris V, Michalides R, et al. (1987) A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol 61:1651–1654PubMedGoogle Scholar
  71. Lan H, Kendziorski CM, Haag JD, Shepel LA, Newton MA, et al. (2001) Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat. Genetics 157:331–339PubMedGoogle Scholar
  72. Lancaster M, Rouse J, Hunter KW (2005) Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17. Mamm Genome 16:120–126PubMedCrossRefGoogle Scholar
  73. Lavin MF, Shiloh Y (1997) The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 15:177–202PubMedCrossRefGoogle Scholar
  74. Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, et al. (2000) An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome 11:883–889PubMedCrossRefGoogle Scholar
  75. Le Voyer T, Rouse J, Lu Z, Lifsted T, Williams M, et al. (2001) Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density. Genomics 74:253–261PubMedCrossRefGoogle Scholar
  76. Lella V, Stieber D, Riviere M, Szpirer J, Szpirer C (2007) Mammary cancer resistance and precocious mammary differentiation in the WKY rat: Identification of 2 quantitative trait loci. Int J Cancer 121:1738–1743PubMedCrossRefGoogle Scholar
  77. Li H, Zhang Y, Su T, Santella RM, Weinstein IB (2006) Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 25:713–721PubMedCrossRefGoogle Scholar
  78. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, et al. (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77:640–644PubMedCrossRefGoogle Scholar
  79. Lu J, Wei Q, Bondy ML, Li D, Brewster A, et al. (2006) Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women < or = 55 years. Carcinogenesis 27:2209–2216PubMedCrossRefGoogle Scholar
  80. Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, et al. (2007) Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol 27:1730–1744PubMedCrossRefGoogle Scholar
  81. Mao JH, Balmain A (2003) Genomic approaches to identification of tumour-susceptibility genes using mouse models. Curr Opin Genet Dev 13:14–19PubMedCrossRefGoogle Scholar
  82. Martin AM, Weber BL (2000) Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92:1126–1135PubMedCrossRefGoogle Scholar
  83. Mathew CG (2006) Fanconi anaemia genes and susceptibility to cancer. Oncogene 25:5875–5884PubMedCrossRefGoogle Scholar
  84. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59PubMedCrossRefGoogle Scholar
  85. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB (2007) Diet and breast cancer: a review of the prospective observational studies. Cancer 109:2712–2749PubMedCrossRefGoogle Scholar
  86. Mikaelian I, Blades N, Churchill GA, Fancher K, Knowles BB, et al. (2004) Proteotypic classification of spontaneous and transgenic mammary neoplasms. Breast Cancer Res 6:R668–679PubMedCrossRefGoogle Scholar
  87. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71PubMedCrossRefGoogle Scholar
  88. Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, et al. (2005) Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 65:10801–10809PubMedCrossRefGoogle Scholar
  89. Moore CJ, Bachhuber AJ, Gould MN (1983) Relationship of mammary tumor susceptibility, mammary cell-mediated mutagenesis, and metabolism of polycyclic aromatic hydrocarbons in four types of rats. J Natl Cancer Inst 70:777–784PubMedGoogle Scholar
  90. Moore CJ, Tricomi WA, Gould MN (1988) Comparison of 7,12-dimethylbenz[a]anthracene metabolism and DNA binding in mammary epithelial cells from three rat strains with differing susceptibilities to mammary carcinogenesis. Carcinogenesis 9:2099–2102PubMedCrossRefGoogle Scholar
  91. Nadeau JH (2001) Modifier genes in mice and humans. Nat Rev Genet 2:165–174PubMedCrossRefGoogle Scholar
  92. Nathanson KL, Weber BL (2001) “Other” breast cancer susceptibility genes: searching for more holy grail. Hum Mol Genet 10:715–720PubMedCrossRefGoogle Scholar
  93. Nathanson KL, Wooster R, Weber BL (2001) Breast cancer genetics: what we know and what we need. Nat Med 7:552–556PubMedCrossRefGoogle Scholar
  94. Nevanlinna H, Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25:5912–5919PubMedCrossRefGoogle Scholar
  95. Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99–109PubMedCrossRefGoogle Scholar
  96. Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, et al. (2005) Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 37:1055–1062PubMedCrossRefGoogle Scholar
  97. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543PubMedCrossRefGoogle Scholar
  98. Parkin DM (2004) International variation. Oncogene 23:6329–6340PubMedCrossRefGoogle Scholar
  99. Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411–414PubMedCrossRefGoogle Scholar
  100. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, et al. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36PubMedCrossRefGoogle Scholar
  101. Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, et al. (2004) Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res 64:5973–5981PubMedCrossRefGoogle Scholar
  102. Quan X, Laes JF, Stieber D, Riviere M, Russo J, et al. (2006) Genetic identification of distinct loci controlling mammary tumor multiplicity, latency, and aggressiveness in the rat. Mamm Genome 17:310–321PubMedCrossRefGoogle Scholar
  103. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165–167PubMedCrossRefGoogle Scholar
  104. Rapp JP (2000) Genetic analysis of inherited hypertension in the rat. Physiol Rev 80:135–172PubMedGoogle Scholar
  105. Richard S, Vogel G, Huot ME, Guo T, Muller WJ, et al. (2007) Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene (online 9 July 2007). doi:10.1038/sj.onc.1210652
  106. Rolstad B (2001) The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses? Immunol Rev 184:136–144PubMedCrossRefGoogle Scholar
  107. Roshani L, Mallon P, Sjostrand E, Wedekind D, Szpirer J, et al. (2005) Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model. Cancer Genet Cytogenet 158:137–141PubMedCrossRefGoogle Scholar
  108. Ross SR (2000) Using genetics to probe host-virus interactions; the mouse mammary tumor virus model. Microbes Infect 2:1215–1223PubMedCrossRefGoogle Scholar
  109. Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938–967PubMedCrossRefGoogle Scholar
  110. Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11:169–178PubMedGoogle Scholar
  111. Russo J, Saby J, Isenberg WM, Russo IH (1977) Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 59:435–445Google Scholar
  112. Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5–73PubMedCrossRefGoogle Scholar
  113. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, et al. (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244–278PubMedGoogle Scholar
  114. Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, et al. (2005) Breast differentiation and its implication in cancer prevention. Clin Cancer Res 11:931s–936sPubMedGoogle Scholar
  115. Sahlin P, Windh P, Lauritzen C, Emanuelsson M, Gronberg H, et al. (2007) Women with Saethre-Chotzen syndrome are at increased risk of breast cancer. Genes Chromosomes Cancer 46:656–660PubMedCrossRefGoogle Scholar
  116. Samuelson DJ, Haag JD, Lan H, Monson DM, Shultz MA, et al. (2003) Physical evidence of Mcs5, a QTL controlling mammary carcinoma susceptibility, in congenic rats. Carcinogenesis 24:1455–1460PubMedCrossRefGoogle Scholar
  117. Samuelson DJ, Aperavich BA, Haag JD, Gould MN (2005) Fine mapping reveals multiple loci and a possible epistatic interaction within the mammary carcinoma susceptibility quantitative trait locus, Mcs5. Cancer Res 65:9637–9642PubMedCrossRefGoogle Scholar
  118. Samuelson DJ, Hesselson SE, Aperavich BA, Zan Y, Haag JD, Trentham-Dietz A, Hampton JM, Mau B, Chen KS, Baynes C, Khaw KT, Luben R, Perkins B, Shah M, Pharoah PD, Dunning AM, Easton DF, Ponder BA, Gould MN (2007) Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proc Natl Acad Sci USA 104:6299–6304PubMedCrossRefGoogle Scholar
  119. Sasco AJ (2003) Breast cancer and the environment. Horm Res 60 Suppl 3:50PubMedCrossRefGoogle Scholar
  120. Sasco AJ, Kaaks R, Little RE (2003) Breast cancer: occurrence, risk factors and hormone metabolism. Expert Rev Anticancer Ther 3:546–562PubMedCrossRefGoogle Scholar
  121. Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, et al. (2006) Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res 66:7793–7800PubMedCrossRefGoogle Scholar
  122. Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, et al. (2007) A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 67:2951–2956PubMedCrossRefGoogle Scholar
  123. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239–1241PubMedCrossRefGoogle Scholar
  124. Shellabarger CJ (1972) Mammary neoplastic response of Lewis and Sprague-Dawley female rats to 7,12-dimethylbenz(a)anthracene or x-ray. Cancer Res 32:883–885PubMedGoogle Scholar
  125. Shellabarger CJ, Stone JP, Holtzman S (1978) Rat differences in mammary tumor induction with estrogen and neutron radiation. J Natl Cancer Inst 61:1505–1508PubMedGoogle Scholar
  126. Shepel LA, Lan H, Haag JD, Brasic GM, Gheen ME, et al. (1998) Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics 149:289–299PubMedGoogle Scholar
  127. Shiloh Y (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31:402–410PubMedCrossRefGoogle Scholar
  128. Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, et al. (2007) A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet 39:93–98PubMedCrossRefGoogle Scholar
  129. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, et al. (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465–475PubMedCrossRefGoogle Scholar
  130. Snyderwine EG (1999) Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms. Cancer Lett 143:211–215PubMedCrossRefGoogle Scholar
  131. Spady TJ, Harvell DM, Snyder MC, Pennington KL, McComb RD, et al. (1998) Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 124:95–103PubMedCrossRefGoogle Scholar
  132. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39:865–869PubMedCrossRefGoogle Scholar
  133. Steffen J, Nowakowska D, Niwinska A, Czapczak D, Kluska A, et al. (2006) Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer 119:472–475PubMedCrossRefGoogle Scholar
  134. Stieber D, Piessevaux G, Riviere M, Laes JF, Quan X, et al. (2007) Isolation of two regions on rat chromosomes 5 and 18 affecting mammary cancer susceptibility. Int J Cancer 120:1678–1683PubMedCrossRefGoogle Scholar
  135. Stone JP, Holtzman S, Shellabarger CJ (1979) Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Sprague-Dawley rats. Cancer Res 39:773–778PubMedGoogle Scholar
  136. Sun T, Gao Y, Tan W, Ma S, Shi Y, et al. (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39:605–613PubMedCrossRefGoogle Scholar
  137. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831–1836PubMedCrossRefGoogle Scholar
  138. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, et al. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333–337PubMedCrossRefGoogle Scholar
  139. Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, et al. (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 13:241–244PubMedCrossRefGoogle Scholar
  140. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, et al. (2007) MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 39:759–769PubMedCrossRefGoogle Scholar
  141. Thompson HJ, Singh M (2000) Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 5:409–420PubMedCrossRefGoogle Scholar
  142. Tong WM, Yang YG, Cao WH, Galendo D, Frappart L, et al. (2007) Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice. Oncogene 26:3857–3867PubMedCrossRefGoogle Scholar
  143. Turner N, Tutt A, Ashworth A (2004) Hallmarks of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer 4:814–819PubMedCrossRefGoogle Scholar
  144. Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, et al. (2000) Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275:36238–36244PubMedCrossRefGoogle Scholar
  145. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, et al. (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432–438PubMedCrossRefGoogle Scholar
  146. Van de Vijver MJ, Nusse R (1991) The molecular biology of breast cancer. Biochim Biophys Acta 1072:33–50PubMedGoogle Scholar
  147. van der Weyden L, Adams DJ, Bradley A (2002) Tools for targeted manipulation of the mouse genome. Physiol Genomics 11:133–164PubMedGoogle Scholar
  148. Vogel HH Jr, Turner JE (1982) Genetic component in rat mammary carcinogenesis. Radiat Res 89:264–273PubMedCrossRefGoogle Scholar
  149. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103–105PubMedCrossRefGoogle Scholar
  150. Wang RA, Zhang H, Balasenthil S, Medina D, Kumar R (2006) PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 25:2931–2936PubMedCrossRefGoogle Scholar
  151. Wang W, Wyckoff JB, Goswami S, Wang Y, Sidani M, et al. (2007) Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res 67:3505–3511PubMedCrossRefGoogle Scholar
  152. Ward JM, Devor-Henneman DE (2004) Mouse models of human familial cancer syndromes. Toxicol Pathol 32 Suppl 1:90–98PubMedCrossRefGoogle Scholar
  153. Welsch CW (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415–3443PubMedGoogle Scholar
  154. Wood GA, Korkola JE, Archer MC (2002) Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes. Carcinogenesis 23:1–9PubMedCrossRefGoogle Scholar
  155. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792PubMedCrossRefGoogle Scholar
  156. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, et al. (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159–161PubMedCrossRefGoogle Scholar
  157. Yang H, Crawford N, Lukes L, Finney R, Lancaster M, et al. (2005) Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 22:593–603PubMedCrossRefGoogle Scholar
  158. Zan Y, Haag JD, Chen KS, Shepel LA, Wigington D, et al. (2003) Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat Biotechnol 21:645–651PubMedCrossRefGoogle Scholar
  159. Zhang ZX, Kumar V, Rivera RT, Pasion SG, Chisholm J, et al. (1989) Suppression of prolactin gene expression in GH cells correlates with site-specific DNA methylation. DNA 8:605–613PubMedCrossRefGoogle Scholar
  160. Zuo T, Wang L, Morrison C, Chang X, Zhang H, et al. (2007) FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129:1275–1286PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Institut de Biologie et de Médecine MoléculairesUniversité Libre de BruxellesGosselies (Charleroi)Belgium

Personalised recommendations